Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opaganib in severe COVID-19 pneumonia
NCT04467840Phase 3Completed
- Sponsor
- RedHill Biopharma
- Start
- Aug 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of Opaganib in COVID-19 pneumonia, sponsored by RedHill Biopharma. Started Aug 2020; status: completed.
02
Drugs
Opaganib
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04467840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04467840.